Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alcon Inc (ALC)

Alcon Inc (ALC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

ALC : 94.51 (-0.38%)
BLCO : 20.76 (+1.91%)
BHC : 8.16 (-0.37%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.1200 (-1.76%)
ALC : 94.51 (-0.38%)
BLCO : 20.76 (+1.91%)
JNJ : 160.09 (-0.93%)
RHHBY : 39.8500 (-1.14%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

/PRNewswire/ -- The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome...

OKYO : 1.1200 (-1.76%)
ALC : 94.51 (-0.38%)
BLCO : 20.76 (+1.91%)
JNJ : 160.09 (-0.93%)
RHHBY : 39.8500 (-1.14%)
Stock Index Futures Plunge on Pressure from Rising Bond Yields, China Data Disappoints

September S&P 500 futures (ESU23) are down -0.61%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.48% this morning as market participants digested the latest U.K. employment data, which fueled...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
NVDA : 141.25 (+0.52%)
X : 39.46 (+2.68%)
MNDY : 302.50 (+1.73%)
TSLA : 259.52 (-1.14%)
KEY : 17.38 (-0.97%)
CMA : 62.72 (+0.08%)
HD : 395.07 (-1.94%)
SU : 38.07 (-1.04%)
ALC : 94.51 (-0.38%)
A : 131.23 (-0.24%)
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the American Society of Cataract and Refractive Surgery...

ALC : 94.51 (-0.38%)
Alcon Announces Results of 2023 Annual General Meeting

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2023 Annual General Meeting (AGM)....

ALC : 94.51 (-0.38%)
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy

The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...

MMED.NE : 14.9000 (+9.48%)
MNMD : 6.45 (-3.01%)
INCY : 73.60 (+12.04%)
SGEN : 228.74 (-0.07%)
PFE : 28.46 (-1.39%)
FBRX : 4.58 (-0.87%)
JAZZ : 111.91 (+0.48%)
ALC : 94.51 (-0.38%)
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have the largest surgical ophthalmic presence at the American Society of Cataract and Refractive...

ALC : 94.51 (-0.38%)
Alcon Publishes Agenda for 2023 Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 5, 2023.

ALC : 94.51 (-0.38%)
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce...

ALC : 94.51 (-0.38%)

Barchart Exclusives

2 Promising Growth Stocks to Buy and Hold for a Decade or Longer
These two growth stocks could be great additions to a long-term buy-and-hold portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar